Robiopsy EU Project has reached its conclusion after bringing together robotics, AI, clinical expertise and innovation management around a shared goal: improving the way prostate biopsy procedures can be planned and performed.
Throughout the project, the consortium worked to translate research results into a more mature prototype, while engaging with clinical, technical and innovation communities through events, networking opportunities and stakeholder dialogue.
The final project video tells this journey through the voices of the partners, the work behind REGOLUS and the vision that guided ROBIOPSY from the beginning.
To watch the video, click here.
A sincere thank you to all partners who contributed to this collaborative effort: Università di Verona (Coordinator), ACMIT Gmbh – Austrian Center for Medical Innovation and Technology, Universitätsklinikum Freiburg, Needleye Robotics and Day One.
We are proud of the path built together and of the contribution ROBIOPSY has made to the development of robotic and AI-enabled solutions for prostate cancer diagnosis. The conversation around their future role in clinical practice continues.
To stay updated, follow our work:
